阿凡托邦是血小板生成素受体（TPO受体）的新型具口服活性激动剂，EC50值为3.3nM，是针对某些导致血小板减少（异常低血小板计数）的病症而开发的药物。
1-Cyclohexylpiperazine
1-(4-Chlorothiophen-2-yl)ethanone
5,6-Dichloropyridine-3-carboxylicacid
4-(4-Chlorothiophen-2-yl)thiazol-2-amine
4-(4-Chlorothiophen-2-yl)-5-(4-cyclohexylpiperazin-1-yl)thiazol-2-amine
5,6-Dichloro-N-(4-(4-chlorothiophen-2-yl)-5-(4-cyclohexylpiperazin-1-yl)thiazol-2-yl)nicotinamide
1-(3-Chloro-5-((4-(4-chlorothiophen-2-yl)-5-(4-cyclohexylpiperazin-1-yl)thiazol-2-yl)carbamoyl)pyridin-2-yl)piperidine-4-carboxylic acid maleate
2-Bromo-1-(4-chlorothiophen-2-yl)ethanone
